June 1, 2021Open Access

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Key points are not available for this paper at this time.

ClinicalTrials.gov NCT02488759; https://clinicaltrials.gov/ct2/show/NCT02488759.

Perguntar à IA

Bookmark

View Full Paper

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Ferris et al. (Tue,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: